Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1991 Feb;72(2):167–173.

Expression of IL-2 receptor p55 and p75 chains by human B lymphocytes: effects of activation and differentiation.

H Zola 1, H Weedon 1, G R Thompson 1, M C Fung 1, E Ingley 1, A J Hapel 1
PMCID: PMC1384479  PMID: 2016116

Abstract

Whilst B cells in human blood can be shown to express interleukin-2 receptor (IL-2R) p55 and p75 chains, using a high-sensitivity immunofluorescence procedure, fresh tonsil B cells did not show detectable levels of expression. Culture of tonsil B cells led to low levels of expression of the p55 chain of the IL-2R, an effect which was dependent on protein synthesis. The level of expression of IL-2R chains could be modulated by culturing in the presence of a number of factors which activate B cells. p55 levels were more readily modulated than p75 levels. IL-4 and combinations of IL-4 with anti-IgM, IL-2 or tumour necrosis factor-beta (TNF-beta) modulated p55 levels, but IL-5 did not. Changes in IL-2R expression were small when compared with other B-cell activation markers such as CD23. When unfractionated tonsil cells were activated with a polyclonal stimulus, the major change was the expression of p55 by T-cell blasts--p75 expression remained low in T and B cells, and p55 expression by B cells remained low.

Full text

PDF
167

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armitage R. J., Cawley J. C. Normal and certain leukaemic B cells express IL-2 receptors without in vitro activation. Clin Exp Immunol. 1986 Feb;63(2):298–302. [PMC free article] [PubMed] [Google Scholar]
  2. Clutterbuck E., Shields J. G., Gordon J., Smith S. H., Boyd A., Callard R. E., Campbell H. D., Young I. G., Sanderson C. J. Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays. Eur J Immunol. 1987 Dec;17(12):1743–1750. doi: 10.1002/eji.1830171210. [DOI] [PubMed] [Google Scholar]
  3. Dagg M. K., Levitt D. Human B-lymphocyte subpopulations. I. Differentiation of density-separated B lymphocytes. Clin Immunol Immunopathol. 1981 Oct;21(1):39–49. doi: 10.1016/0090-1229(81)90193-8. [DOI] [PubMed] [Google Scholar]
  4. Ferro L. M., Zola H. Modulation of expression of the antigen identified by FMC7 upon human B-lymphocyte activation: evidence for differences between activation in vivo and in vitro. Immunology. 1990 Mar;69(3):373–378. [PMC free article] [PubMed] [Google Scholar]
  5. Finkelman F. D., Holmes J., Katona I. M., Urban J. F., Jr, Beckmann M. P., Park L. S., Schooley K. A., Coffman R. L., Mosmann T. R., Paul W. E. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol. 1990;8:303–333. doi: 10.1146/annurev.iy.08.040190.001511. [DOI] [PubMed] [Google Scholar]
  6. Fung M. C., Chiu K. Y., Weber T., Chang T. W., Chang N. T. Detection and purification of a recombinant human B lymphotropic virus (HHV-6) in the baculovirus expression system by limiting dilution and DNA dot-blot hybridization. J Virol Methods. 1988 Jan;19(1):33–42. doi: 10.1016/0166-0934(88)90005-5. [DOI] [PubMed] [Google Scholar]
  7. Galanaud P., Karray S., Llorente L. Regulatory effects of IL-4 on human B-cell response to IL-2. Eur Cytokine Netw. 1990 May-Jun;1(2):57–64. [PubMed] [Google Scholar]
  8. Hatakeyama M., Tsudo M., Minamoto S., Kono T., Doi T., Miyata T., Miyasaka M., Taniguchi T. Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's. Science. 1989 May 5;244(4904):551–556. doi: 10.1126/science.2785715. [DOI] [PubMed] [Google Scholar]
  9. Hitoshi Y., Yamaguchi N., Mita S., Sonoda E., Takaki S., Tominaga A., Takatsu K. Distribution of IL-5 receptor-positive B cells. Expression of IL-5 receptor on Ly-1(CD5)+ B cells. J Immunol. 1990 Jun 1;144(11):4218–4225. [PubMed] [Google Scholar]
  10. Jackson A. L., Matsumoto H., Janszen M., Maino V., Blidy A., Shye S. Restricted expression of p55 interleukin 2 receptor (CD25) on normal T cells. Clin Immunol Immunopathol. 1990 Jan;54(1):126–133. doi: 10.1016/0090-1229(90)90012-f. [DOI] [PubMed] [Google Scholar]
  11. Jelinek D. F., Lipsky P. E. Inhibitory influence of IL-4 on human B cell responsiveness. J Immunol. 1988 Jul 1;141(1):164–173. [PubMed] [Google Scholar]
  12. Jelinek D. F., Lipsky P. E. Regulation of human B lymphocyte activation, proliferation, and differentiation. Adv Immunol. 1987;40:1–59. doi: 10.1016/s0065-2776(08)60237-0. [DOI] [PubMed] [Google Scholar]
  13. Jelinek D. F., Splawski J. B., Lipsky P. E. The roles of interleukin 2 and interferon-gamma in human B cell activation, growth and differentiation. Eur J Immunol. 1986 Aug;16(8):925–932. doi: 10.1002/eji.1830160809. [DOI] [PubMed] [Google Scholar]
  14. Korsmeyer S. J., Greene W. C., Waldmann T. A. Cellular origin of hairy cell leukemia: malignant B cells that express receptors for T cell growth factor. Semin Oncol. 1984 Dec;11(4):394–400. [PubMed] [Google Scholar]
  15. Lee H. K., Xia X., Choi Y. S. IL-4 blocks the up-regulation of IL-2 receptors induced by IL-2 in normal human B cells. J Immunol. 1990 May 1;144(9):3431–3436. [PubMed] [Google Scholar]
  16. Loughnan M. S., Nossal G. J. Interleukins 4 and 5 control expression of IL-2 receptor on murine B cells through independent induction of its two chains. Nature. 1989 Jul 6;340(6228):76–79. doi: 10.1038/340076a0. [DOI] [PubMed] [Google Scholar]
  17. Loughnan M. S., Takatsu K., Harada N., Nossal G. J. T-cell-replacing factor (interleukin 5) induces expression of interleukin 2 receptors on murine splenic B cells. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5399–5403. doi: 10.1073/pnas.84.15.5399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nakanishi K., Malek T. R., Smith K. A., Hamaoka T., Shevach E. M., Paul W. E. Both interleukin 2 and a second T cell-derived factor in EL-4 supernatant have activity as differentiation factors in IgM synthesis. J Exp Med. 1984 Dec 1;160(6):1605–1621. doi: 10.1084/jem.160.6.1605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nishi M., Ishida Y., Honjo T. Expression of functional interleukin-2 receptors in human light chain/Tac transgenic mice. Nature. 1988 Jan 21;331(6153):267–269. doi: 10.1038/331267a0. [DOI] [PubMed] [Google Scholar]
  20. O'Garra A., Barbis D., Wu J., Hodgkin P. D., Abrams J., Howard M. The BCL1 B lymphoma responds to IL-4, IL-5, and GM-CSF. Cell Immunol. 1989 Oct 1;123(1):189–200. doi: 10.1016/0008-8749(89)90279-7. [DOI] [PubMed] [Google Scholar]
  21. Ohashi Y., Takeshita T., Nagata K., Mori S., Sugamura K. Differential expression of the IL-2 receptor subunits, p55 and p75 on various populations of primary peripheral blood mononuclear cells. J Immunol. 1989 Dec 1;143(11):3548–3555. [PubMed] [Google Scholar]
  22. Pène J., Rousset F., Brière F., Chrétien I., Wideman J., Bonnefoy J. Y., De Vries J. E. Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells. The role of soluble CD23 antigen. Eur J Immunol. 1988 Jun;18(6):929–935. doi: 10.1002/eji.1830180615. [DOI] [PubMed] [Google Scholar]
  23. Rolink A. G., Melchers F., Palacios R. Monoclonal antibodies reactive with the mouse interleukin 5 receptor. J Exp Med. 1989 May 1;169(5):1693–1701. doi: 10.1084/jem.169.5.1693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sanderson C. J., Campbell H. D., Young I. G. Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects on human and mouse B cells. Immunol Rev. 1988 Feb;102:29–50. doi: 10.1111/j.1600-065x.1988.tb00740.x. [DOI] [PubMed] [Google Scholar]
  25. Sharon M., Siegel J. P., Tosato G., Yodoi J., Gerrard T. L., Leonard W. J. The human interleukin 2 receptor beta chain (p70). Direct identification, partial purification, and patterns of expression on peripheral blood mononuclear cells. J Exp Med. 1988 Mar 1;167(3):1265–1270. doi: 10.1084/jem.167.3.1265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Smith K. A. The interleukin 2 receptor. Adv Immunol. 1988;42:165–179. doi: 10.1016/s0065-2776(08)60844-5. [DOI] [PubMed] [Google Scholar]
  27. Tsudo M., Kitamura F., Miyasaka M. Characterization of the interleukin 2 receptor beta chain using three distinct monoclonal antibodies. Proc Natl Acad Sci U S A. 1989 Mar;86(6):1982–1986. doi: 10.1073/pnas.86.6.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tsudo M., Uchiyama T., Uchino H. Expression of Tac antigen on activated normal human B cells. J Exp Med. 1984 Aug 1;160(2):612–617. doi: 10.1084/jem.160.2.612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Waldmann T. A., Goldman C. K., Robb R. J., Depper J. M., Leonard W. J., Sharrow S. O., Bongiovanni K. F., Korsmeyer S. J., Greene W. C. Expression of interleukin 2 receptors on activated human B cells. J Exp Med. 1984 Nov 1;160(5):1450–1466. doi: 10.1084/jem.160.5.1450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Waldmann T. A. The multi-subunit interleukin-2 receptor. Annu Rev Biochem. 1989;58:875–911. doi: 10.1146/annurev.bi.58.070189.004303. [DOI] [PubMed] [Google Scholar]
  31. Yoshimoto T., Nakanishi K., Matsui K., Hirose S., Hiroishi K., Tanaka T., Hada T., Hamaoka T., Higashino K. IL-5 up-regulates but IL-4 down-regulates IL-2R expression on a cloned B lymphoma line. J Immunol. 1990 Jan 1;144(1):183–190. [PubMed] [Google Scholar]
  32. Zola H., Mantzioris B. X., Webster J., Kette F. E. Circulating human T and B lymphocytes express the p55 interleukin-2 receptor molecule (TAC, CD25). Immunol Cell Biol. 1989 Aug;67(Pt 4):233–237. doi: 10.1038/icb.1989.35. [DOI] [PubMed] [Google Scholar]
  33. Zola H., Purling R. J., Koh L. Y., Tsudo M. Expression of the p70 chain of the IL-2 receptor on human lymphoid cells: analysis using a monoclonal antibody and high-sensitivity immunofluorescence. Immunol Cell Biol. 1990 Aug;68(Pt 4):217–223. doi: 10.1038/icb.1990.30. [DOI] [PubMed] [Google Scholar]
  34. Zubler R. H., Lowenthal J. W., Erard F., Hashimoto N., Devos R., MacDonald H. R. Activated B cells express receptors for, and proliferate in response to, pure interleukin 2. J Exp Med. 1984 Oct 1;160(4):1170–1183. doi: 10.1084/jem.160.4.1170. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES